MEDIFAST (MED)
(Delayed Data from NYSE)
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 5:54 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.88 USD
+0.18 (0.91%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $19.88 0.00 (0.00%) 5:54 PM ET
1-Strong Buy of 5 1
A Value D Growth B Momentum A VGM
Zacks News
Inter Parfums (IPAR) Partners With G-III Apparel to Fuel Growth
by Zacks Equity Research
Inter Parfums (IPAR) finalizes an agreement with G-III Apparel to become the exclusive worldwide licensee for the Donna Karan and DKNY fragrance brands.
Zacks.com featured highlights Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington
by Zacks Equity Research
Sanderson Farms, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington have been highlighted in this Screen of the Week article.
The J.M. Smucker (SJM) Rewards Investors With Dividend Hike
by Zacks Equity Research
The J.M. Smucker (SJM) rewards shareholders by raising the quarterly dividend. The company is progressing with core priorities.
Dive Into DuPont Analysis & Pick 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap Sanderson Farms (SAFM), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).
Chefs' Warehouse (CHEF) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Chefs' Warehouse (CHEF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Lamb Weston (LW) Stock Up More Than 15% YTD: Here's Why
by Zacks Equity Research
Lamb Weston (LW) benefits from a recovery in the Foodservice business. The company's efforts to boost production capacity and fuel long-term growth are yielding.
Solid Skin Care Business Aids The Estee Lauder Companies (EL)
by Zacks Equity Research
The Estee Lauder Companies (EL) is benefiting from strong e-commerce business. Also, the company's Skin Care portfolio has been performing well.
Strength in Core Priorities Aid Coty (COTY), High Costs Ail
by Zacks Equity Research
Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. However, the company is not immune to the rising inflationary environment.
Conagra Brands (CAG) Q4 Earnings Beat Estimates
by Zacks Equity Research
Conagra Brands (CAG) delivered earnings and revenue surprises of 1.56% and 0.93%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Tyson Foods (TSN) Gains on Solid Brands & Capacity Expansion
by Zacks Equity Research
Tyson Foods (TSN) is focused on higher protein production to cater to the rising demand for protein-packed food. Focus on its e-commerce business bodes well.
This is Why Medifast (MED) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.
Is MEDIFAST (MED) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Greencore Group (GNCGY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Medifast (MED) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Why Medifast (MED) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's How Much You'd Have If You Invested $1000 in Medifast a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Medifast (MED) Benefits From Solid OPTAVIA Lifestyle Solution
by Zacks Equity Research
Medifast (MED) has been gaining from its OPTAVIA lifestyle solution and coaching support system due to consumers' rising inclination toward health.
B&G Foods' (BGS) New Business Unit Structure to Boost Growth
by Zacks Equity Research
B&G Foods (BGS) is forming four business units, Spices & Seasonings, Meals, Frozen & Vegetables and Specialty.
Post Holdings' (POST) Latest Move to Fuel Production Capacity
by Zacks Equity Research
Post Holdings (POST) plans to expand Post Consumer Brands' Sparks cereal facility. Management expects the expansion to conclude in 2025.
Kroger (KR) Beats on Q1 Earnings, Lifts Fiscal 2022 Guidance
by Zacks Equity Research
Kroger (KR) reports better-than-expected first-quarter fiscal 2022 results. The quarter reflects significant investments to enhance product freshness and quality, and expand digital capabilities.
Mondelez (MDLZ) Benefits From Buyouts, Hurt by Cost Woes
by Zacks Equity Research
Mondelez (MDLZ) has been gaining from its prudent acquisitions and strength in emerging markets. However, the company is seeing input cost inflation.
Pilgrim's Pride (PPC) Up More than 25% in 3 Months: Here's Why
by Zacks Equity Research
Pilgrim's Pride (PPC) benefits from long-term investments like automation and focus on service for key customers.
Is MEDIFAST (MED) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hershey (HSY) Benefits From Pricing, Buyouts & Hurt by Costs
by Zacks Equity Research
Hershey (HSY) has been gaining on its pricing power and contributions from buyouts like Pretzels, Dot's and Lily's. However, elevated costs and supply-chain inflation are headwinds.